Product Innovations and Recent Activity in the Cancer Generics Market

Author Information

Bharat Book has 58 Published Articles

India,
Maharashtra,
Navi Mumbai,
Office No.808, Real Tech Park, 8th Floor,,
Plot No. 39/2, Sector-30A,Vashi, Navi Mumbai - 400703

Product Innovations and Recent Activity in the Cancer Generics Market

Posted On : Sep-05-2011 | seen (385) times | Article Word Count : 400 |

Bharat Book added a new report on "Cancer Generics Market Analysis" provides extensive information and rational analysis of the global cancer generics drugs market.

Cancer Generics Market Analysis

Cancer has emerged as one of the major causes of death globally and has made the pharmaceutical & biotech companies proactive to foray research & development to develop new therapies for its treatment. With increasing cancer incidences and competition in the healthcare industry around the world, the cancer market represents a lucrative sector for the generic players around the world due to the fact that price erosion is significantly lower than the other segments. bharatbook.com/detail.asp?id=205592&rt=Cancer-Generics-Market-Analysis.html

According to our new research report, “Cancer Generics Market Analysis”, the global cancer generics market is anticipated to grow at a CAGR of around 27% during 2010-2014. Market growth will be driven by upcoming anti-cancer blockbuster drugs patent expirations and the rising drugs bill that will encourage payers to address the barriers to generics access in order to control costs. As per our research, oncology drugs worth around US$10 Billion are expected to lose patent rights in the US by 2011. As the governments and private players have stepped in the industry across various geographical locations, the future prospects of the market shows immense opportunities to tap on.

Our thorough study on the industry indicates that the Global Cancer generics drugs industry has witnessed a number of product launches and mergers & acquisitions in the past few years. The main focus of the companies has been to introduce effective and quality products in the market so that it gains a worldwide acceptance. With new markets and new products for generics manufacturers within the cancer market, it is anticipated that a harsh environment for companies focusing on novel cancer treatments is about to come. However, within the cancer market, there remains a high level of unmet need, and novel products demonstrating improved clinical attributes to any degree that would be expected to capture the market share from older generic drugs.

On the competitive front, Teva & Hospira are presently the global market leader in cancer generics drugs market. Meanwhile, some Indian companies are also using their experiences within the deregulated markets to produce dossiers and products suited for the regulated markets.

For more information kindly visit : bharatbook.com/detail.asp?id=205592&rt=Cancer-Generics-Market-Analysis.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: bharatbook.com
Follow us on twitter: twitter.com/#!/BharatBook

Re-Publish this Article

<h1>Product Innovations and Recent Activity in the Cancer Generics Market</h1> Author: <a href='http://www.articleseen.com/profile_Bharat Book.aspx'>Bharat Book</a> Cancer Generics Market Analysis

Cancer has emerged as one of the major causes of death globally and has made the pharmaceutical & biotech companies proactive to foray research & development to develop new therapies for its treatment. With increasing cancer incidences and competition in the healthcare industry around the world, the cancer market represents a lucrative sector for the generic players around the world due to the fact that price erosion is significantly lower than the other segments. http://www.bharatbook.com/detail.asp?id=205592&rt=Cancer-Generics-Market-Analysis.html

According to our new research report, “Cancer Generics Market Analysis”, the global cancer generics market is anticipated to grow at a CAGR of around 27% during 2010-2014. Market growth will be driven by upcoming anti-cancer blockbuster drugs patent expirations and the rising drugs bill that will encourage payers to address the barriers to generics access in order to control costs. As per our research, oncology drugs worth around US$10 Billion are expected to lose patent rights in the US by 2011. As the governments and private players have stepped in the industry across various geographical locations, the future prospects of the market shows immense opportunities to tap on.

Our thorough study on the industry indicates that the Global Cancer generics drugs industry has witnessed a number of product launches and mergers & acquisitions in the past few years. The main focus of the companies has been to introduce effective and quality products in the market so that it gains a worldwide acceptance. With new markets and new products for generics manufacturers within the cancer market, it is anticipated that a harsh environment for companies focusing on novel cancer treatments is about to come. However, within the cancer market, there remains a high level of unmet need, and novel products demonstrating improved clinical attributes to any degree that would be expected to capture the market share from older generic drugs.

On the competitive front, Teva & Hospira are presently the global market leader in cancer generics drugs market. Meanwhile, some Indian companies are also using their experiences within the deregulated markets to produce dossiers and products suited for the regulated markets.

For more information kindly visit : http://www.bharatbook.com/detail.asp?id=205592&rt=Cancer-Generics-Market-Analysis.html

Bharat Book Bureau
Tel: +91 22 27578668 
Fax: +91 22 27579131
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: http://twitter.com/#!/BharatBook About the Author: Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world. Article Source: <a href='http://www.articleseen.com/Article_Product-Innovations-and-Recent-Activity-in-the-Cancer-Generics-Market_79591.aspx'> http://www.articleseen.com/Article_Product Innovations and Recent Activity in the Cancer Generics Market_79591.aspx</a>

Article Source : http://www.articleseen.com/Article_Product Innovations and Recent Activity in the Cancer Generics Market_79591.aspx

Author Resource :
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.

Keywords : Cancer, generic, pharmaceutical, healthcare, market, report, demand forecast, market share, Market forecast, Market research,

Category : Health and Fitness : Health and Fitness

Print this Article Send to Friend